Mitsubishi UFJ Trust & Banking Corp Has $8.15 Million Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mitsubishi UFJ Trust & Banking Corp decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 2.4% during the 4th quarter, HoldingsChannel reports. The firm owned 88,620 shares of the medical device company’s stock after selling 2,212 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Cooper Companies were worth $8,147,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Raymond James Financial Inc. acquired a new stake in Cooper Companies in the fourth quarter valued at about $64,826,000. Victory Capital Management Inc. grew its holdings in shares of Cooper Companies by 14.6% during the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after purchasing an additional 574,899 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after purchasing an additional 573,908 shares during the last quarter. Wealthfront Advisers LLC increased its position in Cooper Companies by 4,594.1% during the 4th quarter. Wealthfront Advisers LLC now owns 569,812 shares of the medical device company’s stock worth $52,383,000 after purchasing an additional 557,673 shares in the last quarter. Finally, Alecta Tjanstepension Omsesidigt bought a new position in Cooper Companies in the 4th quarter valued at approximately $49,550,000. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO stock opened at $83.77 on Friday. The stock has a market capitalization of $16.75 billion, a PE ratio of 42.96, a PEG ratio of 2.25 and a beta of 1.02. The business’s 50 day simple moving average is $89.33 and its 200 day simple moving average is $97.29. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on COO shares. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Piper Sandler reaffirmed an “overweight” rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.